These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 3022123)

  • 1. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
    Kniazev PG; Schäfer R; Willecke K; Seits IF
    Vopr Onkol; 1985; 31(6):77-85. PubMed ID: 4024551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogene amplification in human neuroblastomas].
    Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and molecular genetic characterization of the c-Ha-ras 1 oncogene in human breast cancer, malignant melanoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Seĭts IF
    Dokl Akad Nauk SSSR; 1985; 283(4):1011-3. PubMed ID: 3899561
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
    Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
    Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants.
    Weismanová E; Sabová L
    Neoplasma; 1990; 37(6):675-85. PubMed ID: 2274086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against ras activation in human ovarian carcinomas.
    Haas M; Isakov J; Howell SB
    Mol Biol Med; 1987 Oct; 4(5):265-75. PubMed ID: 3320675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of proto-oncogene amplification in human malignant diseases.
    Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
    Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of N-myc in a rhabdomyosarcoma.
    Mitani K; Kurosawa H; Suzuki A; Hayashi Y; Hanada R; Yamamoto K; Komatsu A; Kobayashi N; Nakagome Y; Yamada M
    Jpn J Cancer Res; 1986 Nov; 77(11):1062-5. PubMed ID: 2432051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
    Nikiforova IF
    Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
    Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
    Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
    Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
    Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
    Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.